Upfront Diagnostics is a health care startup founded in November 2017 in Cambridge, United Kingdom. The company's mission revolves around discovering biomarkers to enhance medical diagnosis. Their pioneering product, "LVOne," is the first blood test for large vessel occlusion stroke diagnosis. This breakthrough enables faster and more accurate stroke diagnosis, ultimately improving treatment and aiding clinicians in saving lives. The company's core belief in excellence is evident in their commitment to developing products that empower clinicians, paramedics, and nurses to deliver superior patient care in a more cost-effective manner. Their recent milestone includes securing a £1.60M Seed Round investment on 27th June 2023 from Apex Ventures.
Upfront Diagnostics
Time Is Life
Cambridge, United Kingdom
5 employees
Seed
Total: $3.28M
Health Care
General Information
Get notified when Upfront Diagnostics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Upfront Diagnostics
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United Kingdom Market
Health Care
About Upfront Diagnostics
Taxonomy: biotech, health care, brain stroke, biomarkers, medical diagnosis, Cambridge, blood test, large vessel occlusion, stroke diagnosis, clinicians, paramedics, nurses, patents, innovation
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | •••••• | 1 |
|
27 Jun 2023 |
| Grant | •••••• | 2 |
|
24 Jan 2023 |
| Grant | •••••• | 1 |
|
01 Jun 2021 |
| Pre Seed Round | •••••• | 1 |
|
01 Jan 2019 |
Upfront Diagnostics Alternatives & Competitors
Research and development of AI based innovative stroke diagnosis technologies and full cycle disease...
Developing a fully automated blood test for stroke diagnosis targeting a massive market of 20M peopl...
FAQ About Upfront Diagnostics
Don't just browse. Track.
Signal Tracker monitors Upfront Diagnostics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
